Core Viewpoint - Small-cap stocks, defined as those with market capitalizations between $300 million and $2 billion, are considered higher-risk but can offer significant growth potential, as evidenced by historical examples like Nvidia [1][2][3]. Company Overview - Preformed Line Products (PLPC) is identified as a promising small-cap stock with potential for long-term growth, currently valued at approximately $1.05 billion [4][14]. - The company specializes in designing and manufacturing products for energy, communications, and broadband networks, operating globally with a presence in 20 countries [9]. Financial Performance - In Q3, PLPC reported a revenue increase of 21% year-over-year, reaching $178.1 million, driven by strong performance in both energy and communications sectors [15]. - The net income for Q3, adjusted for one-time items, was $10.3 million, or $2.09 per share, reflecting a 36% year-over-year increase, indicating an expanding profit margin [16]. - Cash generated from operations was $18.9 million, up 102% year-over-year, with free cash flow at $8.5 million, supporting ongoing investments in a new facility in Poland [17]. Growth Drivers - The company is expected to benefit from AI-driven electric grid upgrades and global expansion, as the demand for energy infrastructure grows [8][10]. - The recent acquisition of JAP Telecom enhances PLPC's ability to serve telecommunications needs in South America, contributing to its growth strategy [16]. Insider Ownership - Significant insider ownership, with the Ruhlman family holding between 31% to 48% of shares, aligns the interests of management with those of shareholders [12][11]. Dividend and Tariff Management - PLPC offers a modest dividend yield of approximately 0.39%, which can enhance long-term returns when reinvested [19]. - The company has implemented price increases to mitigate the impact of tariffs, with expectations for full mitigation over time [19].

Core Viewpoint - A class action lawsuit has been filed against Coupang, Inc. for failing to disclose a significant cybersecurity event that impacted the company, leading to a decline in stock price and harming investors [1][2]. Group 1: Allegations - The lawsuit alleges that Coupang had inadequate cybersecurity protocols, allowing a former employee to access sensitive customer information for nearly six months without detection [2]. - The company is accused of not reporting the data breach in compliance with applicable reporting rules, which heightened the risk of regulatory and legal scrutiny [2]. - Following the revelation of the breach, Coupang's stock price experienced a decline, negatively affecting investors [2]. Group 2: Class Action Participation - Shareholders who purchased Coupang securities between April 6, 2025, and December 16, 2025, may be eligible to participate in the class action [1][3]. - Interested shareholders can contact Robbins LLP to serve as lead plaintiff, representing other class members in the litigation [3]. - Shareholders can choose to remain absent from the case while still being eligible for recovery [3]. Group 3: Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless the case is won [4]. - The firm has been dedicated to shareholder rights litigation since 2002, focusing on helping shareholders recover losses and improve corporate governance [4].

Core Insights - The cannabis investment landscape is influenced by federal regulations, investment strategies, and valuation challenges, with a focus on expected industry consolidation and insights for retail investors navigating this complex environment [2][4]. Federal Landscape and Regulatory Changes - President Trump's recent executive order aims to expedite the rescheduling of cannabis and directs collaboration with Congress to define hemp, which may impact CBD products [27][28]. - The executive order does not guarantee immediate changes in business operations, as many companies already operate under the assumption that 280E does not apply to them [29][30]. Investment Strategies and Market Dynamics - The investment approach emphasizes focusing on business fundamentals rather than speculative trading based on regulatory news, which can lead to misinterpretations and volatility in stock prices [32][33]. - Retail investors are cautioned against overreacting to regulatory news, as the actual impact on cash flows and business fundamentals may be minimal [30][31]. Valuation Challenges in the Cannabis Industry - Valuation in the cannabis sector is complicated by varying state regulations, growth trajectories, and market dynamics, making it difficult to establish a consistent growth rate for companies [90][91]. - The industry faces challenges in achieving sustainable profitability as pricing normalizes over time, complicating the valuation of publicly traded cannabis companies [92][96]. Insights on Specific Companies - Grown Rogue is highlighted as a company with a strong cultivation team and a focus on customer-centric operations, which is seen as essential for long-term success in the cannabis industry [44][45]. - Glass House is recognized for its operational capabilities but faces valuation concerns and risks associated with interstate commerce and market competition [66][72][76]. Retail Investor Insights - Retail investors are advised to approach cannabis investments with caution, recognizing the speculative nature of trading around political developments and the importance of understanding the underlying business fundamentals [104][105]. - The Canadian cannabis market is perceived as offering a more level playing field for analysis compared to the U.S. market, which remains challenging for investors [101][102].

Core Points - The U.S. administration under President Donald Trump has initiated a review that may lead to the first shipments of Nvidia's second-most powerful AI chips to China, fulfilling a prior commitment to permit these controversial sales [1] Group 1 - The review could result in significant developments regarding Nvidia's AI chip sales to China [1] - This move aligns with the administration's previous pledge to allow sales of these chips, which have been a topic of debate [1]

U.S. markets moved higher on Thursday, led by the Nasdaq, which climbed nearly 1.4% to 23,006.36. The S&P 500 added almost 0.8% to 6,774.76, while the Dow Jones Industrial Average edged up 0.1% to 47,951.85.These are the top stocks that gained the attention of retail traders and investors through the day:Rivian’s stock surged by 15.03%, closing at $20.28, with an intraday high of $20.33 and a low of $18.26. The stock’s 52-week range is between $20.33 and $10.36. Rivian expanded its hands-free assisted drivi ...

Core Viewpoint - Toyota Motor plans to start selling its U.S.-made Camry sedan, Highlander SUV, and Tundra pickup truck in Japan next year to enhance Japan-U.S. trade relations [1] Group 1 - The introduction of U.S.-made vehicles in Japan is part of Toyota's strategy to strengthen trade ties between Japan and the United States [1] - The specific models targeted for sale include the Camry sedan, Highlander SUV, and Tundra pickup truck [1]

Group 1 - TikTok has reached an agreement to form a joint venture with American investors, granting them a controlling stake in the platform [1][2] - The joint venture will include Oracle, Silver Lake, and MGX, who will collectively own a 45% stake, while ByteDance retains a 20% stake [1][2] - The agreement is expected to close on January 22, ending a prolonged effort by the U.S. government to force a sale of TikTok due to national security concerns [2][3] Group 2 - Oracle's shares rose over 5% in extended trading following the news of the joint venture, despite previous concerns about an AI bubble and reliance on a few major clients [4] - The joint venture comes ahead of a January deadline for TikTok to comply with U.S. ownership requirements or face a potential ban [3]

Oil prices fell in early trading on Friday and were set to close lower for a second straight week, as rising prospects of a Russia-Ukraine peace deal offset concerns over supply disruptions from a blockade of Venezuelan oil tankers. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

The stocks listed here trade at forward earnings multiples of less than 18.Valuations for many stocks are sky-high, and that can make now an unappealing time to invest in the stock market. However, there are still some great value buys that don't involve taking on a lot of risk or investing in unknown companies.Three of the best bargains you can buy today come from the healthcare sector. AstraZeneca (AZN +0.83%), CVS Health (CVS 0.13%), and Pfizer (PFE +0.04%) are all trading at incredibly low valuations wi ...